One of the most common questions we hear from patients at Seaside Ketamine isn’t about whether ketamine will work — it’s about what happens to their antidepressants.
Many patients have been on SSRIs or SNRIs for years — sometimes decades. Some feel the medications have simply stopped working. Others are experiencing side effects they can no longer tolerate: emotional blunting, weight gain, sexual dysfunction, or a creeping sense that they’ve lost something vital about themselves. And many simply want to explore whether they can feel well without being dependent on a daily medication.
The fear of tapering is real. Antidepressant discontinuation syndrome — often called “antidepressant withdrawal” — can involve dizzying, uncomfortable symptoms including brain zaps, flu-like feelings, mood instability, and the potential return of the depression being managed. This fear keeps many people on medications long after they’ve stopped working.
Ketamine changes this equation significantly.
Serotonin-based antidepressants — SSRIs like escitalopram, sertraline, and fluoxetine; SNRIs like venlafaxine and duloxetine — work by increasing serotonin availability in the brain. Over time, the brain adapts to higher serotonin levels by downregulating its own serotonin receptors. When the medication is reduced or stopped, the sudden drop in serotonin activity produces the symptoms of discontinuation syndrome.
Beyond discontinuation syndrome itself, there is the very real risk that the depression being managed by the medication will return — particularly if the underlying drivers of depression have not been addressed. This is the deeper fear, and it is what keeps many patients trapped.
Ketamine works through a fundamentally different mechanism than SSRIs — it targets the glutamate system through NMDA receptor antagonism and stimulates neuroplasticity through BDNF (brain-derived neurotrophic factor) release. This creates several important advantages for patients tapering antidepressants:
Ketamine has no direct interaction with the serotonin tapering process. It doesn’t fill in for missing serotonin in a way that would prevent the brain from adjusting — meaning it doesn’t create the same dependency loop that makes SSRIs hard to stop.
When patients taper SSRIs, the brain’s serotonin system is in a process of adjustment — a vulnerable window during which depressive symptoms are more likely to emerge or intensify. Ketamine’s neuroplasticity-promoting effects create a period of neurological resilience and adaptability during this transition. The brain becomes more capable of forming new, healthier patterns rather than reverting to old ones.
For many patients, ketamine is effective where the SSRI has become ineffective. This means patients aren’t tapering off their medication into a void — they’re transitioning toward a treatment that is actively working. This fundamentally changes the risk calculus of the tapering process.
Some antidepressants carry specific considerations when combined with ketamine:
Medication management and tapering support is a core service at Seaside Ketamine — not an afterthought. We don’t simply administer infusions in isolation. We engage with your complete medication history, coordinate with your existing prescribing physician where appropriate, and develop a tapering timeline that is gradual, evidence-based, and supported by ketamine treatment.
For patients who have been on antidepressants for years and are ready to explore life beyond daily medication, ketamine therapy combined with thoughtful physician-guided medication management represents a genuine, realistic pathway to that goal.
The first step is a conversation. That’s what our free 15-minute consultation is for.
